期刊文献+

托珠单抗对类风湿关节炎合并骨质疏松患者骨代谢的改善作用 被引量:2

The improvement effect of tocilizumab on bone metabolism in the patients with rheumatoid arthritis complicated with osteoporosis
下载PDF
导出
摘要 目的探讨对类风湿关节炎合并骨质疏松患者实施托珠单抗治疗对其骨代谢水平的影响。方法回顾性分析我院2015年9月~2016年9月收集的类风湿关节炎合并骨质疏松患者47例的临床资料。治疗前与治疗后3个月,分别检测患者的骨代谢、骨形成、骨吸收情况,并进行腰、股BMD测量。结果治疗前与治疗后3个月,经骨代谢指标检测与比较,可得患者的铁蛋白水平显著下降(P<0.05);但血磷、血钙、PTH、维生素D水平无明显变化(P均>0.05);经骨吸收与骨形成标检测与比较,可得患者的各项指标均出现明显变化,各项指标检测水平均显著下降(P均<0.05);治疗前后分别对患者的腰、股BMD进行检测,可得与治疗前比较密度均显著增加(P均<0.05)。治疗后患者体内的炎性因子水平均出现明显的下降(P均<0.05)。47例患者均顺利完成整个疗程的治疗,治疗过程中均未出现严重不良反应。结论对类风湿关节炎合并骨质疏松患者实施托珠单抗治疗效果确切,可以改善患者的骨代谢和骨形成、骨吸收情况,减轻骨破坏程度。 Objective To investigate the effect of tocilizumab on the level of bone metabolism in the patients with rheumatoid arthritis complicated with osteoporosis. Methods The clinical data of 47 patients with rheumatoid arthritis combined with osteoporosis in our hospital from September 2015 to September 2016 were retrospectively analyzed. Before treatment and 3 months after treatment,the bone metabolism,bone formation,and bone resQrption were tested and lumbar and femoral BMD was measured. Results Before treatment and 3 months after treatment,by the determination and comparison of bone metabolism indices, the levels of ferritin were significantly decreased (P〈0.05); but the levels of serum phosphorus, calcium, PTH ,vitamin D did not change significantly (P all 〉0.05); according to the determination and comparison of bone resorption and bone formation, all indices were significantly changed in the patients, and the determination levels of all indices were significantly decreased (P all 〈0.05 ); before and after treatment, the lumbar and femoral BMD were detected,and the density was significantly increased compared with that before treatment (Pall 〈0.05). After treatment,the level of inflammatory factors in the patients were significantly decreased (P all 〈0.05). 47 patients successfully completed the entire course of treatment. No serious adverse events were observed during the course of treatment. Conclusion The curative effect of tocilizumab in the patients with rheumatoid arthritis complicated with osteoporosis has an exact effect,which can improve the bone metabolism,bone formation,and bone resorption, and reduce the degree of bone destruction.
出处 《中国现代医生》 2017年第19期18-21,共4页 China Modern Doctor
基金 浙江省金华市社会发展类一般项目(2015-3-032)
关键词 类风湿关节炎 骨质疏松 托珠单抗 骨代谢 骨密度 Rheumatoid arthritis Osteoporosis Tocilizumab Bone metabolism Bone density
  • 相关文献

参考文献20

二级参考文献191

  • 1张江林.类风湿关节炎的骨质疏松研究进展[J].中华风湿病学杂志,2005,9(8):503-505. 被引量:19
  • 2胡大伟,鲍春德,陈顺乐,古洁若,栗占国,孙凌云,韩星海,倪立青.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗类风湿关节炎双盲随机多中心对照临床研究[J].中华风湿病学杂志,2005,9(11):664-668. 被引量:86
  • 3艾脉兴,马丽,赵孟君,王丽英,林冰,王国春,吴东海.依那西普治疗活动性类风湿关节炎的安全性和有效性[J].中国新药杂志,2007,16(15):1208-1211. 被引量:12
  • 4Drossaers-Bakker KW,de Buck M,van Zeben D,et al.Longterm course and outcome of functional capacity in rheumatoid arthritis:the effect of disease activity and radiologic damage over time.Arthritis Rheum,1999,42:1854-1860.
  • 5Eberhardt KB,Fex E.Functional impairment and disability in early rheumatoid arthritis:development over 5 years.J Rheumatol,1995,22:1037-1042.
  • 6Pincus T,Sokka T,Wolfe F.Premature mortality in patients with rheumatoid arthritis:evolving concepts.Arthritis Rheum,2001,44:1234-1236.
  • 7Choy EH,Panayi GS.Cytokine pathways and joint inflammation in rheumatoid arthritis.N Engl J Med,2001,344:907-916.
  • 8Moreland LW,Schiff MH,Baumgartner SW,et al.Etanercept therapy in rheumatoid arthritis:a randomized,controlled trial.Ann Intern Med,1999,130:478-486.
  • 9Weinblatt ME,Kremer JM,Bankhurst AD,et al.A trial of etanercept,a recombinant tumor necrosis factor receptor:Fc fusion protein,in patients with rheumatoid arthritis receiving methotrexate.N Engl J Med,1999,340:253-259.
  • 10Bathon JM,Martin RW,Fleischmann RM,et al.A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.N Engl J Med,2000,343:1586-1593.

共引文献208

同被引文献7

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部